Gene Dantsker

Gene Dantsker is an accomplished professional with extensive experience in advisory and leadership roles across various technology and healthcare sectors. Currently serving as an advisor at io9, Inc., and on the advisory boards of CRISPR QC and TrustFour Technologies, Gene Dantsker also holds the position of Executive Advisor at EvoNexus, a prominent technology startup incubator. Additionally, Gene Dantsker is involved with Carlsmed, Inc. in a leadership role and has contributed as an advisor to several organizations, including KidneyPal and Juno Diagnostics. Previous roles include Medical Device & Life Sciences Principal Segment Lead at Amazon Web Services and senior director at Capsule Technologies. Gene Dantsker holds a Ph.D. in Applied Physics from the University of California, Berkeley, along with an MBA from San Diego State University and additional degrees in Physics and Mathematics from the University of Maryland.